Company Filing History:
2 out of 210 
1 out of 136 
1 out of 1 
Years Active: 2013-2017
Title: Etienne Testa: Innovator in Particle Therapy Verification
Introduction
Etienne Testa is a notable inventor based in Lyons, France. He has made significant contributions to the field of particle therapy verification, holding 2 patents that enhance the precision and effectiveness of charged hadron therapy.
Latest Patents
One of his latest patents is an "Apparatus for particle therapy verification comprising a collimator with multiple openings." This invention relates to a method and apparatus for verifying charged hadron therapy. The apparatus features a collimator with multiple slabs that create an array of slit-shaped openings. These openings are designed to be positioned at a right angle to the beam line, allowing prompt gammas from the target to pass through. The collimator is defined by three geometrical parameters: the width and depth of the openings and a fill factor. Another significant patent is the "Method and device for real-time measurement of a local dose upon bombardment of a target by hadrons by means of prompt gamma rays." This method enables real-time measurement of the local dose received by a target region when bombarded by hadrons. It utilizes prompt gamma rays and neutrons emitted from the target, measured by a detector positioned at a specific distance from the target.
Career Highlights
Etienne Testa has worked with esteemed organizations such as Université Claude Bernard – Lyon 1 and Ion Beam Applications S.A. His work in these institutions has contributed to advancements in the field of particle therapy.
Collaborations
Throughout his career, Testa has collaborated with notable colleagues, including Nicolas Freud and Cedric Ray. Their combined expertise has furthered the development of innovative solutions in particle therapy.
Conclusion
Etienne Testa's contributions to particle therapy verification through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence advancements in medical technology and patient care.